Target intelligence / Profile preview

S100 calcium-binding protein G (S100G) (S100G)

Target
S100G
Molecular classification
S100 family, EF-hand calcium-binding protein, Calcium-binding protein
01

Overview

S100 calcium-binding protein G, commonly known as Calbindin-D9k, is a low-molecular-weight protein belonging to the S100 family of EF-hand calcium-binding proteins (UniProt). It is primarily recognized for its role in the small intestine, where it facilitates the transcellular transport of calcium and acts as a cytosolic buffer to maintain low levels of free calcium, thereby preventing cellular toxicity (PubMed, PMC). Its expression is highly regulated by vitamin D (calcitriol) in the intestine and by sex steroids like estrogen in the uterus and pituitary gland (PMC). Beyond its classical role in mineral homeostasis, Calbindin-D9k has emerged as a significant factor in neuroprotection; studies in knockout models show that its absence leads to increased accumulation of amyloid-beta and alpha-synuclein, as well as endoplasmic reticulum stress-induced apoptosis, linking it to the pathogenesis of Alzheimer's and Parkinson's diseases (PubMed). Additionally, it serves as a sensitive biomarker for detecting the activity of estrogenic endocrine disruptors (PubMed). Therapeutic strategies involving this target focus on restoring calcium homeostasis or mitigating ER stress, often using agents like tauroursodeoxycholic acid in experimental models (PMC).

Other names
Calbindin-D9kCalbindin-3CholecalcinVitamin D-dependent calcium-binding protein, intestinalCABP9K9 kDa CaBP
02

Mechanism of action

Transcriptional induction via vitamin D receptor (VDR) or estrogen receptor (ER) signaling; modulation of intracellular calcium buffering and transcellular transport.

03

Biological functions

Calcium bufferingCalcium transportSignal transductionApoptosis regulationResponse to vitamin DResponse to estrogen
04

Disease associations

Neurodegenerative diseaseAlzheimer's diseaseParkinson's diseaseType 1 diabetesCancerCalcium malabsorption
05

Safety considerations

Calcium homeostasis dysregulationEndoplasmic reticulum stress inductionTissue-specific hormonal sensitivity
06

Interacting drugs

Calcitriol

5 more in the full profile.

07

Biomarkers

Estrogenic activity biomarkerNeurodegeneration risk biomarkerType 1 diabetes risk biomarker

Beyond the preview

Go deeper on S100 calcium-binding protein G (S100G) (S100G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S100 calcium-binding protein G (S100G) (S100G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call